Drug Research
Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it had signed an agreement with Trizell GmbH, to support the manufacturing of...
Press Releases
Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research
Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks. The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks....
Press Releases
AstraZeneca’s Forxiga approved in China for heart failure
AstraZeneca’s Forxiga has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF).
Heart failure (HF) is a life-threatening...
Press Releases
Bayer receives approval for Nubeqa in China for the treatment of men with non-metastatic castration-resistant prostate cancer
The Chinese National Medical Products Administration (NMPA) has approved Nubeqa for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease. Nubeqa has already received regulatory approval in several other...
Clinical Trials
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data from its Phase 1 study of VXA-CoV2-1 showing that its oral COVID-19 tablet vaccine candidate was generally well-tolerated, and immunogenic as measured by multiple...
Press Releases
Syntegon validates first AI-equipped visual inspection system in production line
Syntegon Technology recently installed the first fully validated visual inspection system utilizing Artificial Intelligence (AI) in an automated inspection machine. The installation constitutes a major step in the company’s sustained effort to introduce AI to pharmaceutical visual inspection, thereby...
Press Releases
Recipharm and Medspray launch Resyca joint venture to exploit novel softmist technology for pharmaceutical applications
Global contract development and manufacturing organisation (CDMO), Recipharm, and Medspray BV, a manufacturer of high-tech spray nozzles, announce that they have now completed their joint venture and established Resyca BV.
Resyca will develop and exploit the softmist spray nozzle technology...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















